MuseCell Innovations Enters U.S. Market, Bringing Restorative Stem Cell Therapy Directly to American Patients

Backed by the world’s only clinically validated stem cell platform, MuseCell Innovations is redefining regenerative medicine with breakthrough applications in disease treatment, performance enhancement, and aesthetics

SINGAPORE--(BUSINESS WIRE)--MuseCell Innovations (MCI), the exclusive global licensor of Dezawa MuseCells®, today announced its U.S. launch. By making this restorative therapy available domestically, MCI eliminates the need for overseas patient travel, democratizing access to authentic Dezawa MuseCell® therapy through licensed providers in Florida, Utah, Tennessee and Georgia, with additional states to likely follow.

Dezawa MuseCells® are naturally occurring stem cells with regenerative function found in the human body. Backed by over 15 years of peer-reviewed research, global patents, world-renowned scientists, and an official INN with the World Health Organization (WHO), MCI’s proprietary Dezawa MuseCell® technology offers safer, more effective cellular therapies for aesthetics, performance, and the treatment of diseases, representing a distinct and clinically validated category of stem cells with documented ability to repair, restore and regenerate.

"Regenerative medicine has been held back for years by platforms that lack safety validation and clinical rigor. What we’re building at MCI is different. With our approach, we are transforming what has long been considered untreatable into real-world solutions for patients,” said Dr. Dominik Duscher, President and CEO of MuseCell Innovations. "Bringing this technology to the U.S. through authorized clinical partners is the next evolution in medicine, and we believe it will fundamentally change what patients and physicians believe is possible."

Where Science Meets the Human Need to Heal

Stem cell therapy has moved from experimental to increasingly mainstream over the past decade, driven by a broader cultural shift toward longevity, proactive health, and regenerative medicine. For those living with chronic pain, neurological injury, or conditions conventional medicine has struggled to treat, the focus has shifted from whether regenerative medicine works, to which platform is effective and can be trusted.

Most stem cell therapies on the market today never actually reach the injury or address the root cause. Administered through an IV, they are often trapped before they can heal the rest of the body. Dezawa MuseCells® are stress-resilient and work differently to solve this, detecting sphingosine-1-phosphate (S1P) - a signal released by damaged tissue - and migrating directly to the site of injury via S1PR2 receptors, delivering regenerative support where it's needed most. The result is a platform that doesn't just survive the journey - it's built to complete it.

For Cory Nick, the search for answers began after a traumatic assault left him with severe cranio-cervical instability, a devastating condition in which damaged ligaments can no longer properly stabilize the skull on the spine. With few treatment options available and permanent fusion surgery looming as a last resort, Nick spent over $95,000 across six regenerative procedures in pursuit of structural healing. Nothing worked until Dezawa MuseCells®.

“The biological response from Dezawa MuseCells® was noticeably different and significantly stronger than anything I experienced with other stem cell therapies," Nick stated. "For the first time since my injury, I felt that the underlying connective tissues might actually be responding. Dezawa MuseCells® have the potential to change the future for patients suffering from injuries and ailments that were previously considered impossible to repair. I’m deeply grateful for the groundbreaking work MCI is doing in regenerative medicine.”

Dezawa MuseCells®: Built on Scientific Substance, Traceability and Clinical Discipline

Dezawa MuseCells® were discovered by Professor Mari Dezawa, MD, PhD, a leading expert in regenerative medicine and stem cell research whose work has been studied extensively in Japan. Professor Dezawa ultimately discovered that the most powerful repair cells in the human body, now known as Dezawa MuseCells®, had been overlooked. Unlike generic stem cell products or unverified "Muse-like” offerings on the market, authentic Dezawa MuseCells® are ethically sourced, naturally occurring and immune-tolerant.

Scientifically, Dezawa MuseCells® are differentiated by their safety profile and efficacy mechanism. Unlike induced pluripotent stem cells (iPSCs), which carry a documented risk of tumor formation, they have demonstrated a non-tumorigenic profile across published research, a critical distinction in a market where cancer risk remains a primary clinical concern. Dezawa MuseCells® also express HLA-G, the same biological mechanism that allows embryos to coexist with the maternal immune system without triggering a response. In practice, this means donor-derived cells can be used in clinical settings without immune-matching or immunosuppressive drugs, reducing patient risk and making treatment more accessible than conventional stem cell approaches. This stands in contrast to mesenchymal stem cell (MSC) therapies, where immune reactions, including inflammation and flu-like symptoms, have been documented in 10-15% of cases, limiting both tolerability and broader clinical application.

“When I first identified Muse cells over a decade ago, I knew we were looking at something the body had been doing on its own all along. This field has too often been clouded by products that borrow the language of stem cell science without the rigor behind it. I am proud that MuseCell Innovations has built something different. With this discovery now reaching patients in the United States, we have the ability to change lives in ways I hoped it would when this research began," said Professor Mari Dezawa.

Effective Cellular Therapies for Aesthetics, Performance, and the Treatment of Diseases

At its core, MCI’s focus is on three distinct verticals:

• Dezawa High Performance™ - Designed for elite athletes and high-demand individuals, this vertical supports non-performance enhancing recovery from high-load training, vascular integrity, and long-term physical durability.
• Treatment of Diseases - For practitioners at the forefront of disease - from stroke, heart disease, neurodegeneration, and age-related decline - Dezawa MuseCell® technology offers a clinically studied foundation for longevity protocols and difficult to treat conditions. For example, a Phase 2 randomized controlled trial in stroke demonstrated meaningful improvement in subacute stroke recovery across multiple clinical markers, with patients showing sustained recovery signals up to 52 weeks.
• Dezawa Aesthetics™ - Dezawa MuseExosomes® integrate seamlessly into advanced clinic protocols and precision. The platform supports the skin's own cellular processes, reinforcing structural integrity, improving texture, tone, and elasticity, calming visible redness, and building a foundation for scalp and hair health.

Dezawa MuseCell® therapy has been awarded an International Nonproprietary Name (INN) designation by the WHO, marking a key milestone in its global regulatory pathway. For more information or for healthcare providers interested in Dezawa MuseCell® therapy, visit musecellinnovations.com.

About MuseCell Innovations

MuseCell Innovations (MCI) is the exclusive global licensor of Dezawa MuseCells®, the world's only clinically validated platform of naturally occurring, pluripotent-like stem cells discovered by Professor Mari Dezawa, MD, PhD. Backed by 120+ global publications and multiple human clinical studies, MCI brings a more disciplined, transparent, and scientifically grounded model to regenerative medicine, defined by authenticated cell technology, rigorous traceability, and physician-led access through an exclusive network of licensed labs. MCI's platform supports three therapeutic verticals: Dezawa Aesthetics™, Dezawa High Performance™, and the Treatment of Diseases. For more information, visit musecellinnovations.com and follow the company on Instagram.

MCI does not promote or offer direct-to-consumer treatments and cannot provide advice on individual medical care. Any clinical use of Dezawa MuseCells® occurs under licensed, ethics-reviewed, and jurisdictionally approved frameworks.